Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
- Status
- COMPLETED
- Phase
- PHASE3
Fosamprenavir Versus Other Protease Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
- Status
- COMPLETED
- Phase
- PHASE3
HuMax-CD20 in Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Major Depressive Disorder In The Elderly
- Status
- COMPLETED
- Phase
- PHASE3
Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults
- Status
- COMPLETED
- Phase
- PHASE1
Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Ispinesib In Subjects With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
- Status
- COMPLETED
- Phase
- PHASE3
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1